Tuberculosis and Chest Service Department of Health - List of journal publications related to tuberculosis in Hong Kong
 
Home > Information for doctors > List of journal publications related to tuberculosis in Hong Kong > 1991 - 1995

List of journal publications related to tuberculosis in Hong Kong

(Note: The list below is for quick and easy reference only, and cannot meant to be comprehensive.)

1995

  • Kapur V, Li LL, Hamrick MR, Plikaytis BB, Shinnick TM, Telenti A, Jacobs WR Jr, Banerjee A, Cole S, Yuen KY, et al. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med 1995;119:131-8.
  • Yew WW, Chau CH, Wong PC, Lee J, Wong CF, Cheung SW, Chan CY, Cheng AF. Ciprofloxacin in the management of pulmonary tuberculosis in the face of hepatic dysfunction. Drugs Exp Clin Res 1995;21:79-83.
  • Chan CH, Lai CK, Leung JC, Ho AS, Lai KN. Elevated interleukin-2 receptor level in patients with active pulmonary tuberculosis and the changes following anti-tuberculosis chemotherapy. Eur Respir J 1995;8:70-3.
  • Wong PC, Yew WW, Wong CF, Choi HY. Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement. Eur Respir J 1995;8:866-8.
  • Yew WW, Chau CH. Drug-resistant tuberculosis in the 1990s. Eur Respir J 1995;8:1184-92.
  • Dai DLK, LeeYC. Usefulness of the Mantoux test in screening for active pulmonary tuberculosis in the Hong Kong elderly. Hong Kong Med J 1995;1:195-200.
  • Chong LY, Lo KK. Cutaneous tuberculosis in Hong Kong: a 10-year retrospective study. Int J Dermat 1995;34:26-9.
  • Yuen KY, Chan CM, Chan KS, Yam WC, Ho PL, Chau PY. IS6110 based amplityping assay and RFLP fingerprinting of clinical isolates of Mycobacterium tuberculosis. J Clin Pathol 1995;48:924-8.
  • Chan CH, Or KK, Cheung W, Woo J. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin. J Med 1995;26:43-52.
  • Woo J, Chan C, Chan R, Cheung W, Or K, Chan K. Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters. J Med 1995;26:279-94.
  • Hosker HSR, Lam CW, Ng TK, Ma HK, Chan SL. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 1995;89:3-8.
  • Ip MS, Yuen KY, Chiu EK, Chan JC, Lam WK, Chan TK. Pulmonary infections in bone marrow transplantation: the Hong Kong experience. Respiration 1995;62:80-3.
  • Yew WW, Wong CF, Lee J, Wong PC, Chau CH. Do beta-lactam-beta-lactamase inhibitor combinations have a place in the treatment of multidrug-resistant pulmonary tuberculosis? Tuberc Lung Dis 1995;76:90-2.
  • Yew WW, Chau CH, Wong PC, Choi HY. Ciprofloxacin-induced renal dysfunction in patients with mycobacterial lung infections. Tuberc Lung Dis 1995;76:173-5.
  • Yew WW, Lee J. Pathogenesis of cervical tuberculous lymphadenitis: pathways to anatomic localization. Tuber Lung Dis 1995;76:275-6.
  • Chan CH, Woo J, Or KK, Chan RC, Cheung W. The effect of age on the presentation of patients with tuberculosis. Tuberc Lung Dis 1995;76:290-4.

Back to Top

1994

  • Yew WW, Wong PC, Lee J, Chau CH. Ofloxacin and pulmonary tuberculosis. Chest 1994;105:1624.
  • Yew WW, Wong PC, Lee J, Wong CF. Rapid diagnosis of smear-negative pulmonary tuberculosis. Chest 1994;106:326-7.
  • Wong CF, Yew WW. Ethambutol-induced neutropenia and eosinophilia. Chest 1994;106:1638-9.
  • Yew WW, Chau CH, Lee J, Leung CW. Cholestatic hepatitis in a patient who received clarithromycin therapy for a Mycobacterium chelonae lung infection. Clin Infect Dis 1994;18:1025-6.
  • Yew WW, Chau CH, Tse LS. Does hospitalizing patients with tuberculosis ensure compliance with drug regimens? Clin Infect Dis 1994;19:554-5.
  • Chan SL, Yew WW, Porter JHD, McAdam KPWJ, Allen BW, Dickinson JM, Ellard GA, Mitchison DA. Comparison of Chinese and Western rifapentines and improvement of bioavailability by prior taking of various meals. Int J Antimicrob Agents 1994;3:267-74.
  • Yew WW, Piddock LJ, Li MS, Lyon D, Chan CY, Cheng AF. In-vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother 1994;34:343-51.
  • Tsang DN, Li PC, Ho HF, Lai RW. Mycobacterial diseases and AIDS in Hong Kong. Journal of the Hong Kong Medical Association 1994;46:102-5.
  • Cheng AF, Li MS, Chan CY, Chan CH, Lyon D, Wise R, Lee JC. Evaluation of three culture media and their combinations for the isolation of Mycobacterium tuberculosis from pleural aspirates of patients with tuberculous pleurisy. J Trop Med Hyg 1994;97:249-53.
  • Hoheisel G, Chan KM, Chan HS, Chan KS, Teschler H, Costobel U. Endobronchial tuberculosis: diagnostic features and therapeutic outcome. Respir Med 1994;88:593-7.
  • Chan SL, Wong PC, Tam CM. 4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong. Tuberc Lung Dis 1994;75:245-50.
  • Chan KL, Chan HS, Lui SF, Lai KN. Recurrent acute pancreatitis induced by isoniazid. Tuberc Lung Dis 1994;75:383-5

Back to Top

1993

  • Tsui SY, Yew WW, Li MS, Chan CY, Cheng AF. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum. Antimicrob Agents Chemother 1993;37:1001-3.
  • Yew WW, Wong CF, Wong PC, Lee J, Chau CH. Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin. Clin Infect Dis 1993;17:288-9.
  • Yew WW, Wong PC, Woo HS, Yip CW, Chan CY, Cheng FB. Characterization of Mycobacterium fortuitum isolates from sternotomy wounds by antimicrobial susceptibilities, plasmid profiles, and ribosomal ribonucleic acid gene restriction patterns. Diagn Microbiol Infect Dis 1993;17:111-7.
  • Chan SL. Update on chemotherapy for tuberculosis. Hong Kong Pract 1993;15:2448-53.
  • Yew WW, Tam CM, Chan CY, Li MS, Cheng AF. Lack of activities of amikacin and sulphamethoxazole against Mycobacterium avium-intracellulare. Int J Clin Pharmacol Res 1993;13:65-8.
  • Yuen KY, Chan KS, Chan CM, Ho BS, Dai LK, Chau PY, Ng MH. Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis. J Clin Path 1993;46:318-22.
  • Das S, Chan SL, Allen BW, Mitchison DA, Lowrie DB. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuberc Lung Disease 1993;74:47-5.

Back to Top

1992

  • Woo J, Chan HS. Therapeutic problems in the management of elderly patients with tuberculosis. Adverse Drug React Toxicol Rev 1992;11:13-8.
  • Hong Kong Chest Service/ Tuberculosis Research Centre, Madras/ British Medical Research Council. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992;145:36-41.
  • Yew WW, Lee J. Drug treatment of chronic tuberculous empyema. Chest 1992;101:1741-2.
  • Yew WW, Lau KS, Tse WK, Wong CF. Imipenem in the treatment of lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae: further experience. Clin Infect Dis 1992;15:1046-7.
  • Yew WW, Lee J, Wong PC, Kwan SY. Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction. Int J Clin Pharmacol Res 1992;12:173-8.
  • Woo J, Chan CH, Walubo A, Chan KK. Hydrazine--a possible cause of isoniazid--induced hepatic necrosis. J Med 1992;23:51-9.
  • Chan CHS, Chan RCY, Arnold M, Cheung H, Cheung SW, Cheng A. Bronchoscopy and tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis: a prospective study with the addition of transbronchial biopsy. Q J Med 1992;82:15-23.
  • Chan SL, Yew WW, Ma WK, Girling DJ, Aber VR, Felmingham D, Allen BW, Mitchison DA. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis. Tuberc Lung Dis 1992;73:33-8.
  • Hong Kong Chest Service/ British Medical Research Council. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Tuberc Lung Dis 1992;73:59-67.

Back to Top

1991

  • Hong Kong Chest Service/ Tuberculosis Research Centre, Madras/ British Medical Research Council. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Am Rev Respir Dis 1991;143:262-7.
  • Hong Kong Chest Service/ British Medical Research Council. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampicin, and pyrazinamide. Results at 30 months. Am Rev Respir Dis 1991;143:700-6.
  • Yew WW, Lee J, Chan CY, Cheung SW, Wong PC, Kwan SY. Ofloxacin penetration into tuberculous pleural effusion. Antimicrob Agents Chemother 1991;35:2159-60.
  • Lau SK, Wei WI, Kwan S, Yew WW. Combined use of fine-needle aspiration cytologic examination and tuberculin skin test in the diagnosis of cervical tuberculous lymphadenitis. A prospective study. Arch Otolaryngol Head Neck Surg 1991;117:87-90.
  • Yew WW, Chan CY, Kwan SY, Cheung SW, French GL. Diagnosis of tuberculous pleural effusion by the detection of tuberculostearic acid in pleural aspirates. Chest 1991;100:1261-3.
  • Chan SL. Advances in the Diagnosis of Tuberculosis. JAMA SE Asia 1991;7:11-2.
  • Yew WW, Kwan SY, Wong PC, Fu KH. Percutaneous transthoracic needle biopsies in the rapid diagnosis of pulmonary tuberculosis. Lung 1991;169:285-9.
  • Walubo A, Chan K, Woo J, Chan HS, Wong CL. The disposition of antituberculous drugs in plasma of elderly patients I. Isoniazid and hydrazine metabolite. Methods Find Exp Clin Pharmacol 1991;13:545-50.
  • Walubo A, Chan K, Woo J, Chan HS, Wong CL. The disposition of antituberculous drugs in plasma of elderly patients II. Isoniazid, rifampicin and pyrazinamide. Methods Find Exp Clin Pharmacol 1991;13:551-6.
  • Chan CH, Arnold M, Chan CY, Mak TW, Hoheisel GB. Clinical and pathological features of tuberculous pleural effusion and its long-term consequences. Respiration 1991;58:171-5.
  • Yew WW, Lau KS, Ling MH. Phenytoin toxicity in a patient with isoniazid-induced hepatitis. Tubercle 1991;72:309-10.

Back to Top